Adherium
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.
Also: quip to sell its oral health products at Target; HealthEdge's software suite coming to Fluent Health.